Loading organizations...
Key people at UKI2S.
UKI2S (UK Innovation & Science Seed Fund) is a national public seed investment fund, deploying capital into early-stage businesses and spinouts from scientific and technological innovation. Operating as a publicly funded venture fund, it provides essential capital for companies developing advanced technologies across deep tech, translating groundbreaking research into commercial ventures.
Established over two decades ago as the Rainbow Seed Fund, UKI2S arose from the insight that dedicated early-stage capital was crucial for commercializing scientific research from UK public institutions. Its foundation addressed a significant market gap, transforming public R&D outcomes into viable enterprises, nurturing institutional innovation.
UKI2S serves innovative early-stage companies and academic spinouts across scientific domains, including sectors like space and agri-tech. Its vision is to cultivate a dynamic innovation ecosystem, enabling high-potential ventures to mature and achieve global competitiveness. The fund bridges financing hurdles, propelling UK scientific excellence into market leadership.
Key people at UKI2S.
UKI2S has 3 tracked investments across 3 companies. The latest tracked deal is $5.0M Seed in Antiverse in October 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2024 | Antiverse | $5.0M Seed | Jaromir Zahradka, John Gebeily | G20 Ventures, Innospark Ventures, Angelhub, Tensor Ventures |
| Sep 1, 2023 | Pencil Biosciences | $7.0M Seed | — | Business Growth Fund, Hummingbird Ventures, Octopus Ventures, Jonathan Milner, Gm&c Life Sciences Fund, Martlet Capital, Duncan Johnson, O2H Ventures, Syndicate Room |
| Mar 1, 2021 | Cytoseek | $5.0M Seed | Harry Destecroix | Parkwalk Advisors, Luminous Ventures, Meltwind |